Jardiance Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Empagliflozin in ESKD - A Feasibility Study
Conditions:   Kidney Failure, Chronic;   Heart Failure Interventions:   Drug: Empagliflozin 25 mg thrice-weekly post-hemodialysis dosing;   Drug: Empagliflozin 10 mg daily dosing Sponsors:   University of Mississippi Medical Center;   Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2023 Category: Research Source Type: clinical trials

Drug-Drug Interaction Study of Chiglitazar in Healthy Subjects.
Condition:   T2DM Interventions:   Drug: Chiglitazar;   Drug: Empagliflozin;   Drug: Atorvastatin;   Drug: Valsartan Sponsor:   Chipscreen Biosciences, Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2023 Category: Research Source Type: clinical trials